Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    22045986 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.
Condition: Mycosis Fungoides
Intervention: Drug: CPG 7909
2 Completed
Has Results
CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas
Conditions: Non-Hodgkin Lymphoma;   Mycosis Fungoides
Intervention: Drug: CPG 7909
3 Recruiting In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy
Condition: Low-Grade B-cell Lymphoma
Interventions: Drug: rhuFlt3L/CDX-301;   Drug: Poly-ICLC

Study has passed its completion date and status has not been verified in more than two years.